4//SEC Filing
Singh Enakshi 4
Accession 0001645842-22-000116
CIK 0001645842other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:49 PM ET
Size
5.8 KB
Accession
0001645842-22-000116
Insider Transaction Report
Form 4
Singh Enakshi
Chief Financial Officer
Transactions
- Award
Common Stock
2022-08-12+8,320→ 485,320 total
Footnotes (2)
- [F1]Represents Restricted Stock Units (RSUs) that vest (i) with respect to 50% of the total underlying amount immediately prior to the consummation of the merger contemplated by the Agreement and Plan of Merger ("Merger Agreement") dated July 24, 2022 by and between the Issuer, Ginkgo Bioworks Holdings, Inc. and certain other parties named therein (the date on which the consummation of the Merger occurs, the "Closing Date") and (ii) with respect to the remaining 50% of the total underlying amount, on the six-month anniversary of the Closing Date, subject to the grantee's continuous service through each such vesting date; provided that the RSUs accelerate upon the occurrence of certain qualifying events.
- [F2]Includes 77,000 RSUs that vest 1/3 on November 1, 2022 and the remaining 2/3 on November 1, 2023, subject to the Reporting Person's continued service to the Company through thevesting date, and 250,000 RSUs that vest 1/24 on each monthly anniversary of the first day of the calendar month immediately following the Grant Date, March 11, 2022, subject to thegrantee's continuous service through each such vesting date
Documents
Issuer
Zymergen Inc.
CIK 0001645842
Entity typeother
Related Parties
1- filerCIK 0001846617
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 7:49 PM ET
- Size
- 5.8 KB